Evan Stuart Johnston

Title: Innovator Spotlight: Evan Stuart Johnston

Introduction

Evan Stuart Johnston is an inventive mind based in Blaine, MN, who has made significant contributions to the field of neuromodulation. With a portfolio of four patents, Johnston showcases his expertise in developing innovative solutions aimed at improving sleep therapies for patients.

Latest Patents

Johnston's latest patents represent groundbreaking advancements in closed-loop neuromodulator technology. One notable patent is the "Stimulus Sequencer for a Closed Loop Neuromodulator," which details a system and method for generating tailored sleep therapy stimulus waveforms. This invention allows for stimulus sequence information to be selected from a memory array, ultimately enhancing the efficacy of patient care by utilizing a stimulus generator that adapts according to the stimuli parameters.

Another significant patent by Johnston is focused on "Anti-habituating Sleep Therapy for a Closed Loop Neuromodulator." This innovation describes methods for detecting sleep disorder events and providing an adaptive series of stimuli tailored to each event. By adjusting the stimulation parameters in response to habituation, Johnston's method aims to prevent patients from developing tolerance to their treatment, thus ensuring better therapeutic outcomes.

Career Highlights

Johnston is currently employed at Dymedix Corporation, a healthcare company dedicated to improving patients' lives through innovative medical technology. His work there emphasizes advancing therapeutic technologies, particularly in the area of sleep medicine.

Collaborations

Evan Stuart Johnston collaborates with accomplished professionals such as Reinhold Henke and Alan Bradley Jones. These partnerships contribute to the collective expertise and innovative capacity of their projects, enhancing the impact of their developments within the field.

Conclusion

Evan Stuart Johnston's innovative spirit and dedication to improving sleep therapies are evident in his patents and career. With significant contributions to closed-loop neuromodulator technology, he stands as a key figure in the evolving landscape of healthcare innovation.